
Tazoxpac 4000mg/500mg Injection
Marketer
Celaxis Biotech
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazoxpac 4000mg/500mg Injection
Combithrox, a 4000mg/500mg dual-antibiotic injection, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, the dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is crucial. Common reactions may include nausea, vomiting, diarrhea, and rashes; injection site pain, swelling, or redness are also possible. Persistent or worsening side effects necessitate immediate medical attention. Pre-treatment disclosure of antibiotic allergies, kidney, or liver issues is essential; dosage adjustments or alternative medications may be necessary. While generally safe under medical guidance, its use during pregnancy and breastfeeding requires professional consultation.
Uses of Tazoxpac 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazoxpac 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tazoxpac 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazoxpac 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazoxpac 4000mg/500mg Injection works:
The injectable formulation Tazoxpac, containing 4000mg of Piperacillin and 500mg of Tazobactum, employs a dual-drug approach to combat bacterial infections. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Tazoxpac 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tazoxpac (4000mg/500mg) is usually deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; despite this, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazoxpac (4000mg/500mg) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazoxpac 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Tazoxpac 4000mg/500mg Injection requires careful monitoring. Dosage modification of Tazoxpac 4000mg/500mg Injection may be necessary. A physician's advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Tazoxpac 4000mg/500mg Injection in patients with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification of Tazoxpac 4000mg/500mg Injection may be unnecessary in such cases. Physician consultation is recommended.
What if you forget to take Tazoxpac 4000mg/500mg Injection :
Omit a Tazoxpac 4000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Tazoxpac 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
